Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M9FF
|
|||
Former ID |
DIB002408
|
|||
Drug Name |
ReN-1820
|
|||
Synonyms |
TrkAd5; HNGF, ReNeuron; Human nerve growth factor, ReNeuron; HNGF, Enact/University of Bristol; Human nerve growth factor, Enact/University of Bristol
Click to Show/Hide
|
|||
Indication | Cystitis [ICD-11: GC00] | Terminated | [1] | |
Company |
University of Bristol
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Low-affinity nerve growth factor receptor (NGFR) | Target Info | Inhibitor | [2] |
KEGG Pathway | Ras signaling pathway | |||
Rap1 signaling pathway | ||||
Cytokine-cytokine receptor interaction | ||||
PI3K-Akt signaling pathway | ||||
Neurotrophin signaling pathway | ||||
Transcriptional misregulation in cancer | ||||
Pathway Interaction Database | p75(NTR)-mediated signaling | |||
Neurotrophic factor-mediated Trk receptor signaling | ||||
Reactome | Axonal growth inhibition (RHOA activation) | |||
NRAGE signals death through JNK | ||||
p75NTR negatively regulates cell cycle via SC1 | ||||
Regulated proteolysis of p75NTR | ||||
NADE modulates death signalling | ||||
NRIF signals cell death from the nucleus | ||||
p75NTR recruits signalling complexes | ||||
NF-kB is activated and signals survival | ||||
Axonal growth stimulation | ||||
WikiPathways | Spinal Cord Injury | |||
BDNF signaling pathway | ||||
Signalling by NGF |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017720) | |||
REF 2 | Phosphorylation of Extracellular Signal-Regulated Kinases (pERK1/2) in Bladder Afferent Pathways with Cyclophosphamide (CYP)-Induced Cystitis. Neuroscience. 2009 November 10; 163(4): 1353-1362. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.